Search Results - "Risbo, Nickolaj"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Oseltamivir in pregnancy and birth outcomes by Ehrenstein, Vera, Kristensen, Nickolaj Risbo, Monz, Brigitta Ursula, Clinch, Barry, Kenwright, Andy, Sørensen, Henrik Toft

    Published in BMC infectious diseases (16-10-2018)
    “…Prenatal exposure to influenza or fever is associated with risk of congenital malformations. Oseltamivir is used to treat influenza and to provide…”
    Get full text
    Journal Article
  2. 2

    Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for Romiplostim by Christiansen, Christian Fynbo, Bahmanyar, Shahram, Ghanima, Waleed, Risbo, Nickolaj, Ekstrand, Charlotta, Stryker, Scott, Acquavella, John, Kilpatrick, Karynsa, Frederiksen, Henrik, Nørgaard, Mette, Sørensen, Henrik Toft

    Published in EClinicalMedicine (01-09-2019)
    “…Population-based cohorts of immune thrombocytopenia (ITP) are useful for understanding occurrence, clinical characteristics and long-term clinical course. This…”
    Get full text
    Journal Article
  3. 3

    Selective serotonin reuptake inhibitor use and mortality, postoperative complications, and quality of care in hip fracture patients: a Danish nationwide cohort study by Bruun, Stine Bakkensen, Petersen, Irene, Kristensen, Nickolaj Risbo, Cronin-Fenton, Deirdre, Pedersen, Alma Becic

    Published in Clinical epidemiology (01-01-2018)
    “…To examine the association between selective serotonin reuptake inhibitor (SSRI) use and mortality, postoperative complications, and quality of in-hospital…”
    Get full text
    Journal Article
  4. 4

    Mortality in patients with incident rheumatoid arthritis and depression: a Danish cohort study of 11 071 patients and 55 355 comparators by Pedersen, Jens K, Wang, Lei, Risbo, Nickolaj, Pedersen, Alma B, Andersen, Kjeld, Ellingsen, Torkell

    Published in Rheumatology (Oxford, England) (01-03-2024)
    “…In patients with RA, the association between mortality and depression has been investigated only in patients with prevalent RA. In this study, we estimated the…”
    Get full text
    Journal Article
  5. 5

    Increased risk of mortality after postoperative infection in hip fracture patients by Kjørholt, Kaja Eriksrud, Kristensen, Nickolaj Risbo, Prieto-Alhambra, Daniel, Johnsen, Søren Paaske, Pedersen, Alma Bečić

    Published in Bone (New York, N.Y.) (01-10-2019)
    “…Postoperative infection is a common complication in hip fracture patients and the risk appears to have increased during the last decade. However, the impact of…”
    Get full text
    Journal Article
  6. 6

    Antibiotics in inflammatory arthritis and background population one year before and after diagnosis: a nationwide drug utilisation study by Kragsnaes, Maja S, Risbo, Nickolaj, Pedersen, Jens Kristian, Obel, Niels, Finckh, Axel, Pedersen, Alma B, Ellingsen, Torkell

    Published in Rheumatology (Oxford, England) (27-08-2024)
    “…To describe antibiotic use in patients with inflammatory arthritis (IA) and in the background population (BP) within one year before and after IA diagnosis…”
    Get full text
    Journal Article
  7. 7

    Incidence, Quality of Care, and Mortality in Hip Fracture Patients in the Course of the COVID Pandemic: A Population-Based Cohort Study by Pedersen, Alma B, Risbo, Nickolaj, Viberg, Bjarke L, Palm, Henrik, Röck, Niels Dieter

    “…We assessed the incidence, quality of in-hospital care, and mortality for hip fracture (HF) patients in Denmark before and during the coronavirus disease…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Utilization patterns and factors associated with persistence of new users of anti-osteoporosis treatment in Denmark: a population-based cohort study by Pedersen, Alma B., Risbo, Nickolaj, Kafatos, George, Neasham, David, O’Kelly, James, Ehrenstein, Vera

    Published in Archives of osteoporosis (11-01-2023)
    “…Summary Persistence with initial treatment was highest after 1 year, decreasing afterwards. Persistence was highest for denosumab followed by alendronate. We…”
    Get full text
    Journal Article
  11. 11

    Romiplostim Treatment Pattern of Adult Chronic Immune Thrombocytopenia in Routine Clinical Care in Three Nordic Countries by Nørgaard, Mette, Kristensen, Nickolaj Risbo, Frederiksen, Henrik, Bahmanyar, Shahram, Ghanima, Waleed, Alam, Naufil, Ording, Anne Gulbech, Sørensen, Henrik Toft, Christiansen, Christian Fynbo

    Published in Blood (29-11-2018)
    “…Introduction Romiplostim was approved in 2009 in Europe for treatment of adult chronic immune thrombocytopenia (cITP) in splenectomized patients, refractory to…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Routine clinical care for chronic immune thrombocytopenia purpura in Denmark, 2009-2015 by Ording, Anne Gulbech, Kristensen, Nickolaj Risbo, Frederiksen, Henrik, Alam, Naufil, Bahmanyar, Shahram, Ghanima, Waleed, Nørgaard, Mette, Christiansen, Christian Fynbo

    Published in Hematology (Luxembourg) (01-01-2019)
    “…Objectives: To describe routine treatment and clinical characteristics of patients with chronic ITP (cITP). Methods: We used data from Danish nationwide…”
    Get full text
    Journal Article